MISTI ZOTZ: Open Payments
NPI 1063142156 · PARADISE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 33 payments from 11 companies in 2025. Trend: 2023 $204 · 2024 $564 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $291 |
| Corium, LLC | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Tris Pharma Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| GE HEALTHCARE | 1 | $16 |
Products named: VRAYLAR, Azstarys, Auvelity, REXULTI, Qelbree, Jornay PM, Onyda XR, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
